ADMA Biologics Inc
NASDAQ:ADMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ADMA Biologics Inc
NASDAQ:ADMA
|
US |
|
Atos SE
F:AXI0
|
FR |
|
H
|
Hino Motors Ltd
DUS:HMO
|
JP |
|
Fobi AI Inc
XTSX:FOBI
|
CA |
|
Lippo Karawaci Tbk PT
IDX:LPKR
|
ID |
|
Jensen-Group NV
F:XD1
|
BE |
|
Jfrog Ltd
NASDAQ:FROG
|
US |
|
Posco Holdings Inc
KRX:005490
|
KR |
|
M
|
Mogo Inc
TSX:ORIO
|
CA |
|
U
|
Ulta Beauty Inc
F:34U
|
US |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
XMUN:MUV2
|
DE |
|
Millicom International Cellular SA
F:M4M1
|
LU |
|
Take Solutions Ltd
NSE:TAKE
|
IN |
Bankruptcy Probability
ADMA Biologics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
ADMA Biologics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
ADMA Biologics Inc
NASDAQ:ADMA
|
1.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
402.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
191.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
156B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
64.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
37.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
ADMA Biologics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, ADMA Biologics Inc has total debt of 193.6m USD. This includes both short-term (0 USD) and long-term (193.6m USD) debt.
You can find a full breakdown on its Balance Sheet.
